Results 241 to 250 of about 163,370 (376)

Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1H) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase

open access: yesChemMedChem, Volume 21, Issue 10, 27 May 2026.
A novel 3‐hydroxy‐2,3‐dihydroquinazolinone scaffold is identified as a cell‐active KDM4A inhibitor through an orthogonal screening cascade minimizing assay interference. Integrated biochemical, biophysical, and proteomic validation reveals compound 6i as a bona fide binder that increases H3K9 methylation in cells, highlighting both a promising ...
Alessandra Feoli   +13 more
wiley   +1 more source

Hot-Carrier Injection and Millisecond Charge Separation from a Robust Heteroleptic Iron(II) Chromophore Immobilized on TiO<sub>2</sub>. [PDF]

open access: yesJ Am Chem Soc
Whittemore T   +11 more
europepmc   +1 more source

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.

open access: yesThe Lancet, 2018
T. Powles   +23 more
semanticscholar   +1 more source

Affari di camorra. Famiglie, imprenditori e gruppi criminali

open access: yes, 2015
Castellano, Carolina   +2 more
core  

Validación de la versión en castellano del cuestionario 'Community of Inquiry'

open access: diamond, 2019
Belén Ballesteros Velázquez   +2 more
openalex   +2 more sources

The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial. [PDF]

open access: yesOncologist
Guerrero-Ramos F   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy